IN171746B - - Google Patents

Info

Publication number: IN171746B
Authority: IN; India
Prior art keywords: overindulgence; symptoms; treating; effective amount; acetaminophen
Prior art date: 1989-11-02

Application number

IN907/CAL/90A

Other languages

English (en)

Inventor

William Joseph Goldman

Thomas Neil Gates

Original Assignee

Mcneil Ppc Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-02

Filing date

1990-10-29

Publication date

1992-12-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23709269&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN171746(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-10-29 Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc

1992-10-16 Priority to IN757CA1992 priority Critical patent/IN176327B/en

1992-12-26 Publication of IN171746B publication Critical patent/IN171746B/en

Links

RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
208000024891 symptom Diseases 0.000 abstract 2
229940122957 Histamine H2 receptor antagonist Drugs 0.000 abstract 1
230000000202 analgesic effect Effects 0.000 abstract 1
210000004211 gastric acid Anatomy 0.000 abstract 1
239000000938 histamine H1 antagonist Substances 0.000 abstract 1
239000003485 histamine H2 receptor antagonist Substances 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
229960005489 paracetamol Drugs 0.000 abstract 1
229940126409 proton pump inhibitor Drugs 0.000 abstract 1
239000000612 proton pump inhibitor Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Indole Compounds (AREA)

IN907/CAL/90A 1989-11-02 1990-10-29 IN171746B (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
IN757CA1992 IN176327B (fr)	1989-11-02	1992-10-16

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US43083789A	1989-11-02	1989-11-02

Publications (1)

Publication Number	Publication Date
IN171746B true IN171746B (fr)	1992-12-26

Family

ID=23709269

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN907/CAL/90A IN171746B (fr)	1989-11-02	1990-10-29

Country Status (14)

Country	Link
EP (1)	EP0426479B1 (fr)
JP (1)	JPH03206052A (fr)
KR (1)	KR910009254A (fr)
AT (1)	ATE101515T1 (fr)
AU (1)	AU646230B2 (fr)
CA (1)	CA2028746C (fr)
DE (1)	DE69006684T2 (fr)
ES (1)	ES2057439T3 (fr)
GR (1)	GR1002097B (fr)
IE (1)	IE64953B1 (fr)
IN (1)	IN171746B (fr)
NZ (1)	NZ235877A (fr)
PT (1)	PT95753A (fr)
ZA (1)	ZA908775B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0550083T3 (da) *	1991-12-06	1999-10-11	Glaxo Group Ltd	Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra
WO1994007541A1 (fr) *	1992-09-29	1994-04-14	Merck & Co., Inc.	Combinaisons d'ibuprofene-antihistaminique anti-h¿2?
GB9221414D0 (en) *	1992-10-13	1992-11-25	Glaxo Group Ltd	Pharmaceutical compositions
US5648355A (en) *	1994-02-09	1997-07-15	Kos Pharmaceutical, Inc.	Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
SE9600072D0 (sv) *	1996-01-08	1996-01-08	Astra Ab	New oral formulation of two active ingredients II
SE9600070D0 (sv) *	1996-01-08	1996-01-08	Astra Ab	New oral pharmaceutical dosage forms
ZA975444B (en) *	1996-06-20	1998-12-21	Mcneil Ppc Inc	Acetaminophen and meclizine hydrochloride analgesics
WO1998058637A1 (fr) *	1996-06-20	1998-12-30	Mcneil-Ppc	Analgesique a base d'acetaminophene et de diphenhydramine
DE19801811B4 (de) *	1998-01-19	2004-12-23	Stada Arzneimittel Ag	Pharmazeutische Zubereitung zur oralen Verabreichung
US7799766B2 (en)	1998-04-08	2010-09-21	Theta Biomedical Consulting & Development Co., Inc.	Composition for treating hormonally-dependent cancers
US7906153B2 (en)	1998-04-08	2011-03-15	Theta Biomedical Consulting & Development Co., Inc.	Anti-inflammatory compositions for treating multiple sclerosis
US20050220909A1 (en)	2004-03-30	2005-10-06	Theoharides Theoharis C	Composition for protection against superficial vasodilator flush syndrome
GB9911017D0 (en) *	1999-05-13	1999-07-14	Zeneca Ltd	Pharmaceutical compositions
AU4198899A (en) *	1999-05-20	2000-12-12	Par Pharmaceutical, Inc.	Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
WO2000074784A1 (fr) *	1999-06-09	2000-12-14	Eli Lilly And Company	Combinaison pour le traitement du gain de poids lie a la prise de medicaments antipsychotiques comprenant un antipsychotique atypique et un antagoniste de type h2
SE0000774D0 (sv)	2000-03-08	2000-03-08	Astrazeneca Ab	New formulation
MXPA03007888A (es) *	2001-03-08	2003-12-04	Astrazeneca Ab	Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos.
AU2002305758B2 (en)	2001-06-01	2006-09-07	Nuvo Pharmaceuticals (Ireland) Designated Activity Company	Pharmaceutical compositions for the coordinated delivery of NSAIDs
US8206741B2 (en)	2001-06-01	2012-06-26	Pozen Inc.	Pharmaceutical compositions for the coordinated delivery of NSAIDs
SE0102993D0 (sv)	2001-09-07	2001-09-07	Astrazeneca Ab	New self emulsifying drug delivery system
US20040121004A1 (en) *	2002-12-20	2004-06-24	Rajneesh Taneja	Dosage forms containing a PPI, NSAID, and buffer
US20040185032A1 (en) *	2003-03-18	2004-09-23	David Burrell	Compositions and methods for treating colic
US7923043B2 (en)	2004-03-30	2011-04-12	Theta Biomedical Consulting & Development Co., Inc.	Method for protecting humans against superficial vasodilator flush syndrome
US7776873B2 (en) *	2005-12-01	2010-08-17	Yuhan Corporation	Method for treating damage to gastric mucosa
ES2590604T3 (es) *	2008-01-04	2016-11-22	Schabar Research Associates Llc	Composición que comprende un analgésico y un antihistamínico
US9220698B2 (en)	2008-09-09	2015-12-29	Pozen Inc.	Method for delivering a pharmaceutical composition to patient in need thereof
KR20120030106A (ko)	2009-06-25	2012-03-27	아스트라제네카 아베	Ｎｓａｉｄ-연관된 궤양의 발생 위험이 있는 환자의 치료 방법
US9176146B2 (en)	2009-08-03	2015-11-03	Theta Biomedical Consulting & Development Co., Inc.	Methods of treating autism spectrum disorders and compositions for same
US9050275B2 (en)	2009-08-03	2015-06-09	Theta Biomedical Consulting & Development Co., Inc.	Methods of screening for and treating autism spectrum disorders and compositions for same
EP2797600A4 (fr)	2011-12-28	2015-09-16	Pozen Inc	Compositions et procédés d'administration d'oméprazole plus acide acétylsalicylique améliorés
US11324727B2 (en)	2020-07-15	2022-05-10	Schabar Research Associates, Llc	Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
KR20230051164A (ko)	2020-07-15	2023-04-17	샤바르 리서치 어소시에이츠 엘엘씨	급성 통증의 치료 및 속쓰림의 중증도 및/또는 위험의 감소를 위한 이부프로펜 및 파모티딘으로 구성된 단위 경구 투여 조성물
US12514846B2 (en)	2020-07-15	2026-01-06	Schabar Research Associates Llc	Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2105193B (en) *	1981-09-04	1984-09-12	Glaxo Group Ltd	Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
US4522826A (en) *	1984-02-08	1985-06-11	Richardson-Vicks Inc.	Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4757060A (en) *	1986-03-04	1988-07-12	Bristol-Myers Company	Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers

1990
- 1990-10-29 NZ NZ235877A patent/NZ235877A/xx unknown
- 1990-10-29 IN IN907/CAL/90A patent/IN171746B/en unknown
- 1990-10-31 AU AU65689/90A patent/AU646230B2/en not_active Ceased
- 1990-10-31 PT PT95753A patent/PT95753A/pt not_active Application Discontinuation
- 1990-10-31 CA CA002028746A patent/CA2028746C/fr not_active Expired - Lifetime
- 1990-11-01 KR KR1019900017661A patent/KR910009254A/ko not_active Ceased
- 1990-11-01 GR GR900100786A patent/GR1002097B/el not_active IP Right Cessation
- 1990-11-01 IE IE394690A patent/IE64953B1/en not_active IP Right Cessation
- 1990-11-01 ES ES90311995T patent/ES2057439T3/es not_active Expired - Lifetime
- 1990-11-01 ZA ZA908775A patent/ZA908775B/xx unknown
- 1990-11-01 AT AT90311995T patent/ATE101515T1/de not_active IP Right Cessation
- 1990-11-01 EP EP90311995A patent/EP0426479B1/fr not_active Revoked
- 1990-11-01 DE DE69006684T patent/DE69006684T2/de not_active Revoked
- 1990-11-02 JP JP2298713A patent/JPH03206052A/ja active Pending

Also Published As

Publication number	Publication date
JPH03206052A (ja)	1991-09-09
NZ235877A (en)	1992-09-25
ES2057439T3 (es)	1994-10-16
CA2028746C (fr)	1995-12-26
EP0426479A1 (fr)	1991-05-08
AU646230B2 (en)	1994-02-17
CA2028746A1 (fr)	1991-05-03
GR900100786A (el)	1992-04-17
AU6568990A (en)	1991-05-09
IE903946A1 (en)	1991-05-08
DE69006684D1 (de)	1994-03-24
KR910009254A (ko)	1991-06-28
EP0426479B1 (fr)	1994-02-16
ZA908775B (en)	1992-07-29
ATE101515T1 (de)	1994-03-15
PT95753A (pt)	1991-09-30
GR1002097B (en)	1995-12-28
DE69006684T2 (de)	1994-06-09
IE64953B1 (en)	1995-09-20

Publication	Publication Date	Title
IN171746B (fr)	1992-12-26
BR9814327A (pt)	2000-10-03	Compostos de tiouréia e benzamida, composições e pro-cessos para tratamento ou prevenção de doenças infla-matórias e arteriosclerose
IL93556A0 (en)	1990-11-29	Stabilized nitric oxide-primary amine complexes useful as cardiovascular agents
FI944712A7 (fi)	1995-04-08	Suun kautta annettavia opioidisia kestovaikutteisia formulaatioita
NL300152I2 (nl)	2006-05-01	Preparaat dat een tramadolverbinding en aceetaminofen bevat en de toepassing ervan.
BR9806060A (pt)	1999-08-31	Composto, composição farmacêutica e processos para tratar um paciente sofrendo de um estado doentio, para inibir o fator xa, e, para inibir a formação de trombina.
DK1586322T3 (da)	2008-12-01	Sammensætninger indeholdende thalidomid og dextamethason til behandling af cancer
WO1992019617A3 (fr)	1992-12-10	Composes de dibenzoxazepine substituee, compositions pharmaceutiques et procedes d'utilisation
NO924169D0 (no)	1992-10-29	Preparat omfattende et tramadolmateriale og et ikke-stereoid antiinflammatorisk legemiddel
AP9701041A0 (en)	1999-01-10	Pyridylpyrrole compounds.
EP0460062A4 (en)	1992-07-01	Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
PT1057826E (pt)	2003-08-29	Derivados carboxamidicos dimericos substituidos processo para a sua preparacao e as composicoes farmaceuticas que os contem
NO954073D0 (no)	1995-10-13	Sammensetninger for inhibisjon, kontroll og regresjon av angiogenesen inneholdende hyaluronsyre og NSAID
DK0613687T3 (da)	1999-12-06	Anvendelse af pregnanderivat til behandling af tumorer
IL159241A0 (en)	2004-06-01	Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
WO2001003688A3 (fr)	2002-06-20	Traitement de troubles induits par une cycloxygenase-2 au moyen de composes a base d'acides gras conjugues
HU229440B1 (en)	2013-12-30	Analgesic and anti-inflammatory compositions containing gox-2 inhibitors
AU8900498A (en)	1999-03-01	Compounds and pharmaceutical compositions thereof for eliciting analgesic effects
PL318539A1 (en)	1997-06-23	Inhibition of biosynthesis
ZA989356B (en)	1998-11-16	Pharmaceutical preparations
ES8301230A1 (es)	1982-12-01	Un procedimiento para la preparacion de 1-fenil-5-amidotetrazoles.
SE8504612L (sv)	1985-10-04	Analgetiska och antiinflammatoriska kompositioner innefattande difenhydramin och forfaranden for anvendning av dessa
BG100965A (en)	1998-08-31	New therapeutical injection-type analgetic pharmaceutical composition containing nimesulid (4-nitro, 2-phenoxyphenylmetanesulphonamide) for intramuscular administration and method for its preparation
MX9606137A (es)	1998-01-31	Composiciones y metodos para el tratamiento de tumores.
IT1107771B (it)	1985-11-25	Composizione farmaceutica antiartritica ed antiinfiammatoria